DE69624116D1 - Verfahren zur behandlung von allergischem asthma - Google Patents

Verfahren zur behandlung von allergischem asthma

Info

Publication number
DE69624116D1
DE69624116D1 DE69624116T DE69624116T DE69624116D1 DE 69624116 D1 DE69624116 D1 DE 69624116D1 DE 69624116 T DE69624116 T DE 69624116T DE 69624116 T DE69624116 T DE 69624116T DE 69624116 D1 DE69624116 D1 DE 69624116D1
Authority
DE
Germany
Prior art keywords
allergic asthma
treating allergic
treating
asthma
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69624116T
Other languages
English (en)
Other versions
DE69624116T3 (de
DE69624116T2 (de
Inventor
B Fick
M Jardieu
B Schoenhoff
J Shire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69624116(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69624116D1 publication Critical patent/DE69624116D1/de
Application granted granted Critical
Publication of DE69624116T2 publication Critical patent/DE69624116T2/de
Publication of DE69624116T3 publication Critical patent/DE69624116T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69624116T 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma Expired - Lifetime DE69624116T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50801495A 1995-07-27 1995-07-27
US508014 1995-07-27
PCT/US1996/012275 WO1997004807A1 (en) 1995-07-27 1996-07-24 Methods for treatment of allergic asthma

Publications (3)

Publication Number Publication Date
DE69624116D1 true DE69624116D1 (de) 2002-11-07
DE69624116T2 DE69624116T2 (de) 2003-06-18
DE69624116T3 DE69624116T3 (de) 2009-07-09

Family

ID=24021032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69624116T Expired - Lifetime DE69624116T3 (de) 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma

Country Status (16)

Country Link
EP (1) EP0841946B2 (de)
JP (1) JP4153560B2 (de)
CN (2) CN101172100A (de)
AR (1) AR003468A1 (de)
AT (1) ATE225185T1 (de)
AU (1) AU715338B2 (de)
CA (1) CA2226624C (de)
DE (1) DE69624116T3 (de)
DK (1) DK0841946T4 (de)
ES (1) ES2186796T5 (de)
IL (1) IL122733A (de)
MX (1) MX9800760A (de)
PT (1) PT841946E (de)
RU (1) RU2229288C2 (de)
WO (1) WO1997004807A1 (de)
ZA (2) ZA966075B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
WO1999045777A1 (en) * 1998-03-10 1999-09-16 The Children's Hospital Of Philadelphia Compositions and methods for treatment of asthma
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1324776B2 (de) * 2000-10-12 2018-03-21 Genentech, Inc. Niederviskose konzentrierte proteinformulierungen
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
BRPI0316092B8 (pt) 2002-11-08 2021-05-25 Ablynx Nv anticorpos de domínio único direcionados contra o fator de necrose tumoral alfa e usos para os mesmos
JP2006520584A (ja) 2002-11-08 2006-09-14 アブリンクス エン．ヴェー． 安定化単一ドメイン抗体
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
DE102006009437A1 (de) * 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
JP2010516747A (ja) * 2007-01-29 2010-05-20 バルティオン テクニリーネン トゥトキムスケスクス ＩｇＥを主成分とする新規試薬の製造方法
AR065368A1 (es) 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige
EP2052736A1 (de) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroidhormon-Formulierungen und ihre Verwendungen
CA2991162A1 (en) * 2007-12-21 2009-07-02 Aptevo Biotherapeutics Llc Stabilized factor ix formulations containing trehalose
ES2511844T3 (es) * 2007-12-21 2014-10-23 F. Hoffmann-La Roche Ag Formulación de anticuerpo
KR20110079693A (ko) 2008-10-29 2011-07-07 와이어쓰 엘엘씨 단일 도메인 항원 결합 분자의 정제 방법
AR073997A1 (es) * 2008-10-29 2010-12-15 Wyeth Corp Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
WO2011073234A2 (en) 2009-12-15 2011-06-23 Ascendis Pharma As Growth hormone composition
CN102533704A (zh) * 2010-12-30 2012-07-04 上海雅心生物技术有限公司 即配即用型的胰蛋白酶制剂
JP6014116B2 (ja) * 2011-03-31 2016-10-25 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ヒト・プログラム死受容体ｐｄ−１に対する抗体の安定製剤および関連治療
SG10201604104PA (en) * 2011-10-25 2016-07-28 Prothena Therapeutics Ltd Antibody formulations and methods
KR102276304B1 (ko) * 2013-09-27 2021-07-14 한미약품 주식회사 지속형 인간 성장 호르몬 제제
CN104707146B (zh) * 2013-12-16 2019-04-16 浙江海正药业股份有限公司 一种含有阿达木单抗的药物组合物
GB201610198D0 (en) 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
US11845798B2 (en) 2017-05-02 2023-12-19 Merck Sharp & Dohme Llc Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
UA125971C2 (uk) 2017-07-25 2022-07-20 Джянгсу Хенгруй Медісін Ко., Лтд. Фармацевтична композиція, яка містить протеїновий комплекс il-15, та її застосування
CN110732023B (zh) * 2018-07-18 2023-06-16 江苏恒瑞医药股份有限公司 一种her2抗体药物组合物及其用途
CA3185192A1 (en) 2020-07-10 2022-01-13 Sujun DENG Anti-ige engineered antibody and application thereof
TW202409078A (zh) * 2022-07-18 2024-03-01 中國大陸商蘇州創勝醫藥集團有限公司 穩定之包含抗gremlin1抗體的藥物製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) * 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3853636T3 (de) * 1987-12-31 1999-04-08 Tanox Biosystems Inc Antigene epitope, die sich ausschliesslich auf ige-tragenden b-lymphocyten befinden.
WO1993019197A1 (en) * 1992-03-20 1993-09-30 Immunet Human monoclonal antibodies and methods for human monoclonal antibody production
JPH07118168A (ja) * 1993-10-19 1995-05-09 Tomoyasu Ra ＩｇＥ産生抑制剤
ES2219640T3 (es) * 1992-09-24 2004-12-01 Novartis Ag Anticuerpos monoclonales reformados contra un isotopo de inmunoglobulina.
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
MX9800760A (es) 1998-04-30
JPH11510172A (ja) 1999-09-07
DE69624116T3 (de) 2009-07-09
ZA966240B (en) 1998-01-23
DK0841946T3 (da) 2003-02-10
CN101172099B (zh) 2012-02-15
JP4153560B2 (ja) 2008-09-24
WO1997004807A1 (en) 1997-02-13
AU6638196A (en) 1997-02-26
CA2226624A1 (en) 1997-02-13
ES2186796T5 (es) 2009-04-01
IL122733A (en) 2001-09-13
EP0841946B2 (de) 2008-10-15
IL122733A0 (en) 1998-08-16
AR003468A1 (es) 1998-08-05
DK0841946T4 (da) 2009-02-16
EP0841946B1 (de) 2002-10-02
RU2229288C2 (ru) 2004-05-27
PT841946E (pt) 2003-02-28
ZA966075B (en) 1998-01-19
DE69624116T2 (de) 2003-06-18
AU715338B2 (en) 2000-01-20
CN101172099A (zh) 2008-05-07
CN101172100A (zh) 2008-05-07
ES2186796T3 (es) 2003-05-16
EP0841946A1 (de) 1998-05-20
CA2226624C (en) 2013-07-16
ATE225185T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
DE69624116D1 (de) Verfahren zur behandlung von allergischem asthma
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE696923T1 (de) Verfahren zur behandlung endo-ostealer materialen
ATE230606T1 (de) Verfahren zur vorbeugung und behandlung von allergien
DE69701714T2 (de) Verfahren zur behandlung von glassubstraten
DE69331469D1 (de) Verfahren zur behandlung von abfällen
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69417018D1 (de) Verfahren zur behandlung von teilchenmaterial
DE69624625T2 (de) Verfahren und Vorrichtung zur Behandlung von Organohalogenkomponenten
DE69613446D1 (de) Verfahren zur Behandlung von wässerigem Strom
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE69518824D1 (de) Verfahren zur behandlung von bremsscheiben
ATE232919T1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69802904T2 (de) Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
DE69905263T2 (de) Verfahren zur dekorativen behandlung von oberflächen
DE69634207D1 (de) Verfahren zur behandlung von böden und/oder schüttgütern
DE69429341T2 (de) Verfahren zur behandlung von flüssigkeiten
DE69301029T2 (de) Verfahren zur behandlung und leimung von papiersubstraten
DE69533397D1 (de) Verfahren zur behandlung von hypertonie
DE69507537D1 (de) Verfahren zur Behandlung von Strukturen mit Silikonzusammensetzungen
ATA82393A (de) Verfahren zur behandlung von gasen
DE69504147D1 (de) Verfahren und Vorrichtung zur Behandlung von Aerosolen
ATA183195A (de) Verfahren zur behandlung von organen und vorrichtung hierfür

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings